Genitourinary Cancer News

ASCO and the Association of Community Cancer Centers have jointly developed recommendations for improving equity, diversity and inclusion in cancer clinical trials.

Most patients with cancer demonstrated antibody responses to COVID-19 vaccination after two doses of the mRNA-1273 vaccine, according to an observational study published in JAMA Oncology.

Efforts to limit overuse of surveillance testing and treatment for low-risk nonmuscle-invasive bladder cancer are needed to alleviate increasing costs of care, results of a population-based cohort study suggested.

Nivolumab plus ipilimumab failed to extend OS compared with standard first-line chemotherapy for patients with unresctable or metastatic urothelial carcinoma whose tumor cells expressed PD-L1 at 1% or greater.

Although most cancer centers may not screen every patient at every visit, I believe in it whole-heartedly, and this is what we do at Rush University. If we believe in the value of asking patients how they are doing, it’s hard to justify excluding certain visits from this practice, particularly considering we aren’t very good about predicting when any individual patient might be struggling.

Studies consistently have shown patients with cancer have a higher risk for suicide than the general public.

THOROFARE, NJ — Healio is set to host the inaugural hematology/oncology Disruptive Innovators Award Reception during the American Society of Clinical Oncology Annual Meeting. The event will take place on June 4, 2022, at the Hyatt Regency McCormick Place in Chicago, Illinois.

Click here to read the Cover Story, “ Pandemic proves telehealth ‘works in saving lives’ and ‘that we have an inequitable system’ ”

Over the last decade, “telehealth” became a buzzword in conversations about health care innovation.

Patients using dialysis die from cancer at twice the rate as individuals of the same age and sex in the general population, according to data published in the American Journal of Kidney Diseases.